The identification of a specific diminished astrocyte subpopulation in AD, characterised by low GFAP expression and high expression of AQP4 and CD63, proteins associated with Aβ clearance and tau protein binding, suggests a loss of protective astrocytic functions in disease progression [108]. The gene discussed is MAPT; the disease is Alzheimer disease.